An oral polio vaccine strain that cannot revert to virulence is needed Wouldn't it be nice to have a better sort of oral polio vaccine? Widespread use of the oral vaccine has brought the eradication of polio tantalisingly within reach. Since 1988 when the world embarked on an effort to wipe out the disease entirely, the number of cases has fallen by 99.8 per cent. Developed by an American scientist, Albert Sabin,...

Health activists say new policy may not address the weaknesses in ongoing routine immunisation programmes and would flood poor countries with new Vaccines When the global health leaders meet in Geneva from May 21 to 26 for the World Health Organization's 65th General Assembly, introducing new Vaccines in the low- and middle-income countries would be high on their agenda. A “global draft vaccine action plan”, available on WHO's website, details the implementation...

The debate about essential-medicine pricing and access in India illustrates the difficulties inherent in establishing policies that serve conflicting public interests in achieving goals such as caring well and ensuring safety for all, while also pursuing financially-sustainable success in scientific innovation and trade. It highlights problems facing those interested in continuing drug and Vaccines development and ensuring that, once marketed, such products contribute effectively to improving public health. Modern pharmaceuticals...

Ignoring widespread concern over the safety, efficacy and cost of pentavalent Vaccines, India’s central health ministry has, this month, approved inclusion of the prophylactic cocktail in the universal immunisation programme in seven of its provinces. Pentavalent vaccine doses, a cocktail of five antigens in a single shot, confers immunity against five paediatric diseases - diphtheria, pertussis, tetanus, hepatitis B and haemophilus influenza type b (Hib), with the last one considered particularly...

-BBC Global efforts to cut the number of deaths from measles have fallen short of World Health Organization (WHO) targets. An analysis published in the Lancet said deaths had fallen by 74% between 2000 and 2010, but the target was 90%. Outbreaks in Africa and delays in vaccination programmes in India have stalled progress, researchers say. A new campaign to tackle the disease has been launched, which will combine measles and rubella jabs. In 2000...